Using Siponimod to treat Alzheimer's disease
Repurposing Siponimod for Alzheimer's Disease
This study is looking at whether Siponimod, a medicine made for multiple sclerosis, can also help people with Alzheimer's by targeting different brain pathways to slow down the disease, and it will keep an eye on how patients' thinking and health change during treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Joseph's Hospital and Medical Center NIH-funded |
| Lab location | 1 site (Phoenix, United States) |
| Project ID | NIH-10671526 on NIH RePORTER |
What this research studies
This research investigates the potential of repurposing Siponimod, a medication originally developed for multiple sclerosis, to treat Alzheimer's disease. The approach focuses on targeting multiple molecular pathways involved in Alzheimer's, which may help slow down or alter the disease's progression. By collaborating with Novartis, the study aims to leverage existing knowledge about Siponimod's effects on the brain and immune system. Patients may be monitored for changes in cognitive function and overall health as part of the treatment process.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults diagnosed with Alzheimer's disease or those showing early signs of cognitive decline.
Not a fit: Patients with other forms of dementia or those who are not diagnosed with Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option that may slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in repurposing medications like Siponimod for neurological conditions, indicating potential for success in this novel application.
Where this research is happening
Phoenix, United States
- St. Joseph's Hospital and Medical Center — Phoenix, United States (Active)
Researchers
- Principal investigator: Sabbagh, Marwan Noel — St. Joseph's Hospital and Medical Center
- Study coordinator: Sabbagh, Marwan Noel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.